SCHEMBL29930901

SCHEMBL29930901

COc1ccc(-c2nn(-c3cccc(OCc4ccccc4)c3)c3ncccc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 1/20 0.53
CDK2 P24941 1/20 0.53
ALDH1A1 P00352 3/20 0.48
NPSR1 Q6W5P4 3/20 0.48
HTT P42858 2/20 0.48
LMNA P02545 2/20 0.48
MAOB P27338 1/20 0.47
GABRA1 P14867 3/20 0.45
GABRG2 P18507 3/20 0.45
GABRB3 P28472 3/20 0.45
GABRA5 P31644 3/20 0.45
GABRA3 P34903 3/20 0.45
GABRA2 P47869 3/20 0.45
MAPT P10636 5/20 0.45
THRB P10828 1/20 0.45
BCHE P06276 2/20 0.44
LIPC P11150 1/20 0.44
ACHE P22303 1/20 0.44
LIPE Q05469 1/20 0.44
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9876903 0.86 CCNA2 (0.53) CCNA2CDK2ALDH1A1LMNAMAOB
SCHEMBL9234476 0.77 TNK2 (0.44) CCNA2CDK2ALDH1A1LMNAKDM4E
SCHEMBL9877072 0.77 GSK3B (0.43)
SCHEMBL9876738 0.77 TP53 (0.54) CCNA2CDK2ALDH1A1NPSR1LMNA
SCHEMBL9876909 0.76 LSS (0.44) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL9876523 0.76 PTGER1 (0.39) CCNA2CDK2MAPTTSHRMAPK1
SCHEMBL9876890 0.74 PTGER1 (0.50) CCNA2CDK2ALDH1A1NPSR1HTT
SCHEMBL9876520 0.74 PTGER1 (0.38) CCNA2CDK2MAPTTSHRMAPK1
SCHEMBL30879907 0.73 SRC (0.48) LMNAKDM4EDYRK1APOLBTSHR
SCHEMBL9235073 0.73 FABP4 (0.51) CCNA2CDK2ALDH1A1NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed